IP Library Granted Patent US 12,265,600
Granted Patent B2
US 12,265,600 · App. 18/135,279 · Granted Apr 1, 2025

Audio authentication systems and methods for prescription processes

Inventors: Andrew Schweinfurth (Chicago, IL); Julija Alegra Petkus (Oak Park, IL); Gunjan Dhanesh Bhow (Menlo Park, CA)
Assignee: WALGREEN CO.
G06F21/32G06F3/0481G06F3/167G06F21/6245G06Q50/265G10L15/22G10L17/00G10L17/06G10L17/22G10L25/51G16H10/60G16H20/10G16H40/20G16H40/63G16H80/00G10L2015/223G10L2015/228
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,265,600
App. No.
18/135,279
Granted
Apr 1, 2025
Kind
B2
Abstract

Methods and systems may incorporate voice interaction and other audio interaction to facilitate access to prescription related information and processes. Particularly, voice/audio interactions may be utilized to achieve authentication to access prescription-related information and action capabilities. Additionally, voice/audio interactions may be utilized in performance of processes such as obtaining prescription refills and receiving reminders to consume prescription products.

Claims (34)

1. A computer-implemented method performed via one or more computer processors, the method comprising:

obtaining an indication of an attempt by a user to access a prescription resource associated with a patient, the user being a person other than the patient, and the indication being received from a first device of the user other than the patient;

causing an audio tone to be produced by a speaker in the first device associated with the user;

obtaining an indication that a microphone in a second device associated with the patient detected the produced audio tone; and

authenticating the user to access the prescription resource based at least in part upon obtaining the indication that the microphone detected the produced audio tone.

2. The computer-implemented method of claim 1 , further comprising providing one or more interactive user interfaces to be provided to the first device or the second device to facilitate access to the prescription resource.

3. The computer-implemented method of claim 2 , wherein providing the one or more user interfaces comprises providing an interactive voice interface to the first device or the second device.

4. The computer-implemented method of claim 2 , wherein providing the one or more user interfaces comprises providing an interactive graphical user interface to the first device or the second device.

5. The computer-implemented method of claim 1 , wherein the audio tone is a non-audible tone.

6. The computer-implemented method of claim 1 , wherein causing the microphone of the second device to detect the produced audio tone includes causing the second device to activate the microphone.

7. The computer-implemented method of claim 1 , wherein authenticating the user to access the prescription resource includes using the detection of the produced audio tone in combination with one or more further authentication factors.

8. A computing system comprising:

one or more processors; and

one or more memories storing non-transitory computer executable instructions that, when executed by the one or more processors, cause the computing system to:

obtain an indication of an attempt by a user to access a prescription resource associated with a patient, the user being a person other than the patient, and the indication being received from a first device of the user other than the patient;

cause an audio tone to be produced by a speaker in the first device associated with the user;

obtain an indication that a microphone in a second device associated with the patient detected the produced audio tone; and

authenticate the user to access the prescription resource based at least in part upon obtaining the indication that the microphone detected the produced audio tone.

9. The computing system of claim 8 , wherein the non-transitory computer executable instructions, when executed by the one or more processors, further cause the computing system to provide one or more interactive user interfaces to the first device or the second device to facilitate access to the prescription resource.

10. The computing system of claim 9 , wherein the one or more user interfaces comprise an interactive voice interface.

11. The computing system of claim 9 , wherein the one or more user interfaces comprise an interactive graphical user interface.

12. The computing system of claim 8 , wherein the audio tone is a non-audible tone.

13. The computing system of claim 8 , wherein the instructions to cause the microphone of the second device to detect the produced audio tone include instructions to cause the second device to activate the microphone.

14. The computing system of claim 8 , wherein the instructions to authenticate the user include instructions to authenticate the user based upon the detection of the produced audio tone in combination with one or more further authentication factors.

15. One or more non-transitory computer readable media storing non-transitory computer executable instructions that, when executed by one or more processors of one or more computers, cause one or more computers to:

obtain an indication of an attempt by a user to access a prescription resource associated with a patient, the user being a person other than the patient, and the indication being received from a first device of the user other than the patient;

cause an audio tone to be produced by a speaker in the first device associated with the user;

obtain an indication that a microphone in a second device associated with the patient detected the produced audio tone; and

authenticate the user to access the prescription resource based at least in part upon obtaining the indication that the microphone detected the produced audio tone.

16. The one or more non-transitory computer readable media of claim 15 , wherein the non-transitory computer executable instructions, when executed by the one or more processors, further cause the computing system to provide one or more interactive user interfaces to the first device or the second device to facilitate access to the prescription resource.

17. The one or more non-transitory computer readable media of claim 16 , wherein the one or more user interfaces comprise an interactive voice interface.

18. The one or more non-transitory computer readable media of claim 16 , wherein the one or more user interfaces comprise an interactive graphical user interface.

19. The one or more non-transitory computer readable media of claim 15 , wherein the audio tone is a non-audible tone.

20. The one or more non-transitory computer readable media of claim 15 , wherein the instructions to authenticate the user include instructions to authenticate the user based upon the detection of the produced audio tone in combination with one or more further authentication factors.

Assignments (3)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 28, 2025
From: WALGREEN CO.
To: SIXTH STREET LENDING PARTNERS, AS COLLATERAL AGENT
Reel/Frame 072606/0878 →
SECURITY INTEREST Recorded Aug 28, 2025
From: WALGREEN CO.; DUANE READE; WALGREENS SPECIALTY PHARMACY LLC; WALGREENS BOOTS ALLIANCE, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 072679/0926 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2023
From: SCHWEINFURTH, ANDREW; PETKUS, JULIJA ALEGRA; BHOW, GUNJAN DHANESH
To: WALGREEN CO.
Reel/Frame 063354/0291 →
Continuity (3)
Continuation 16808019 · Mar 3, 2020
Provisional Application 62902110 · Sep 18, 2019
Related Publication 20230259596A1 · Aug 17, 2023
References Cited (40)
US 7853241B1 · Harrison · 2010 [cited by applicant]
US 8032397B2 · Lawless · 2011 [cited by applicant]
US 8095381B2 · Simons et al. · 2012 [cited by applicant]
US 8588765B1 · Harrison · 2013 [cited by applicant]
US 10057227B1 · Hess et al. · 2018 [cited by applicant]
US 10410451B1 · Khalil · 2019 [cited by examiner]
US 20080141353A1 · Brown · 2008 [cited by applicant]
US 20090024416A1 · McLaughlin et al. · 2009 [cited by applicant]
US 20130060569A1 · Fu et al. · 2013 [cited by applicant]
US 20130253936A1 · Harvey · 2013 [cited by applicant]
US 20140119520A1 · Jaiswal et al. · 2014 [cited by applicant]
US 20140142971A1 · Panagakos · 2014 [cited by applicant]
US 20140284348A1 · Cheng · 2014 [cited by applicant]
US 20150081321A1 · Jain · 2015 [cited by applicant]
US 20160378949A1 · Fu et al. · 2016 [cited by applicant]
US 20170086129A1 · Tzannes et al. · 2017 [cited by applicant]
US 20170161439A1 · Raduchel et al. · 2017 [cited by applicant]
US 20170213001A1 · Harrison · 2017 [cited by applicant]
US 20170220762A1 · Toupin et al. · 2017 [cited by applicant]
US 20180068103A1 · Pitkanen et al. · 2018 [cited by applicant]
US 20180293358A1 · Sooudi et al. · 2018 [cited by applicant]
US 20190114685A1 · Postrel · 2019 [cited by applicant]
US 20190228850A1 · Ramaci · 2019 [cited by applicant]
US 20190267123A1 · Stueckemann et al. · 2019 [cited by applicant]
US 20190279647A1 · Jones et al. · 2019 [cited by applicant]
US 20190362064A1 · Zhang et al. · 2019 [cited by applicant]
US 20200059468A1 · Wolosewicz · 2020 [cited by examiner]
US 20200118658A1 · Kalashian · 2020 [cited by examiner]
US 20200323738A1 · Bear · 2020 [cited by examiner]
US 20210081517A1 · Atkinson et al. · 2021 [cited by applicant]
US 20210287794A1 · Alden et al. · 2021 [cited by applicant]
US 20210319872A1 · Valentine · 2021 [cited by applicant]
US 20210398633A1 · Baum et al. · 2021 [cited by applicant]
WO WO2019002327A1 · 2019 [cited by applicant]
European Patent Application No. 20195204.1, Extended European Search Report, dated Feb. 11, 2021. [cited by applicant]
European Patent Application No. 20195206, Extended European Search Report, mailed Feb. 11, 2021. [cited by applicant]
European Patent Application No. 20195196.9, Extended European Search Report, dated Feb. 15, 2021. [cited by applicant]
European Patent Application No. 20195199.3, Extended European Search Report, dated Feb. 15, 2021. [cited by applicant]
European Patent Application No. 2019/5210.8, Extended European Search Report, dated Feb. 16, 2021. [cited by applicant]
European Patent Application No. 20195210.8, Examination Report, dated Dec. 1, 2023. [cited by applicant]